Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) kicked off On Friday, up 3.53% from the previous trading day, before settling in for the closing price of $37.68. Over the past 52 weeks, TNXP has traded in a range of $6.76-$130.00.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 73.03%. While this was happening, its average annual earnings per share was recorded 93.13%. With a float of $7.35 million, this company’s outstanding shares have now reached $7.36 million.
The extent of productivity of a business whose workforce counts for 81 workers is very important to gauge. In terms of profitability, gross margin is 29.81%, operating margin of -721.51%, and the pretax margin is -1146.27%.
Tonix Pharmaceuticals Holding Corp (TNXP) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Tonix Pharmaceuticals Holding Corp is 0.07%, while institutional ownership is 6.31%. The most recent insider transaction that took place on May 15 ’25, was worth 86,200. In this transaction Chief Executive Officer of this company bought 4,000 shares at a rate of $21.55, taking the stock ownership to the 4,005 shares.
Tonix Pharmaceuticals Holding Corp (TNXP) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 93.13% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 88.07% during the next five years compared to 73.03% growth over the previous five years of trading.
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) Trading Performance Indicators
Take a look at Tonix Pharmaceuticals Holding Corp’s (TNXP) current performance indicators. Last quarter, stock had a quick ratio of 11.64. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 28.59.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2930.78, a number that is poised to hit -2.77 in the next quarter and is forecasted to reach -6.08 in one year’s time.
Technical Analysis of Tonix Pharmaceuticals Holding Corp (TNXP)
The latest stats from [Tonix Pharmaceuticals Holding Corp, TNXP] show that its last 5-days average volume of 1.91 million was superior to 1.31 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 8.37%.
During the past 100 days, Tonix Pharmaceuticals Holding Corp’s (TNXP) raw stochastic average was set at 70.07%, which indicates a significant increase from 22.73% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 3.97 in the past 14 days, which was higher than the 3.17 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $38.54, while its 200-day Moving Average is $25.04. Now, the first resistance to watch is $40.52. This is followed by the second major resistance level at $42.03. The third major resistance level sits at $44.46. If the price goes on to break the first support level at $36.58, it is likely to go to the next support level at $34.15. The third support level lies at $32.64 if the price breaches the second support level.
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) Key Stats
The company with the Market Capitalisation of 287.00 million has total of 7,357K Shares Outstanding. Its annual sales at the moment are 10,090 K in contrast with the sum of -130,040 K annual income. Company’s last quarter sales were recorded 2,430 K and last quarter income was -16,830 K.
